Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 121 to 135 of 167 results for urinary tract infections

  1. Sacral nerve stimulation for idiopathic chronic non-obstructive urinary retention (IPG536)

    Evidence-based recommendations on sacral nerve stimulation for idiopathic chronic non-obstructive urinary retention. This involves implanting a stimulator device into the upper buttock to restore the ability to empty the bladder voluntarily.

    Interventional procedures guidance
    Published
    25 November 2015
    View recommendations

    Sections for IPG536

  2. Bladder management strategies:- What are the long-term risks and effects on quality of life of different bladder management strategies for lower urinary tract dysfunction in people with neurological disease?

    quality of life of different bladder management strategies for lower urinary tract dysfunction in people with neurological...

    Research recommendation
    Published
    9 June 2015

  3. Pentosan polysulfate sodium for treating bladder pain syndrome (TA610)

    Evidence-based recommendations on pentosan polysulfate sodium (Elmiron) for bladder pain syndrome in adults.

    Technology appraisal guidance
    Published
    13 November 2019
    View recommendations

    Sections for TA610

  4. Laparoscopic deroofing of simple renal cysts (IPG226)

    Evidence-based recommendations on laparoscopic deroofing of simple renal cysts. This involves draining the cyst and removing part of the cyst wall through small cuts in the abdomen (keyhole surgery).

    Interventional procedures guidance
    Published
    25 July 2007
    View recommendations

    Sections for IPG226

  5. High-intensity focused ultrasound for prostate cancer (IPG118)

    Evidence-based recommendations on high-intensity focused ultrasound for treating prostate cancer. This involves inserting a probe through the rectum that gives out a beam of ultrasound to heat and destroy the cancerous prostate tissue.

    Interventional procedures guidance
    Published
    23 March 2005
    View recommendations

    Sections for IPG118

  6. The NGAL Test for early diagnosis of acute kidney injury (MIB3)

    NICE has developed a medtech innovation briefing (MIB) on the NGAL Test for early diagnosis of acute kidney injury .

    Medtech innovation briefing
    Published
    4 February 2014

  7. S-Cath System for suprapubic catheterisation (MIB68)

    NICE has developed a medtech innovation briefing (MIB) on the S-Cath System for suprapubic catheterisations

    Medtech innovation briefing
    Published
    10 June 2016

  8. Canagliflozin in combination therapy for treating type 2 diabetes (TA315)

    Evidence-based recommendations on canagliflozin (Invokana) in combination therapy for treating type 2 diabetes in adults.

    Technology appraisal guidance
    Published
    25 June 2014
    View recommendations

    Sections for TA315

  9. Symptoms and signs of recurrent UTI:  Do the symptoms and signs of UTI in babies, children and young people aged under 16 years differ in those with a history of recurrent UTIs compared with those without a history of recurrent UTI?

    Source guidance details Comes from guidance Urinary tract infection in under 16s: diagnosis and management...

    Research recommendation
    Published
    4 August 2022

  10. Symptoms and signs of long-term (chronic) UTI: What symptoms and signs do children and young people with long-term (chronic) UTI report and what do they perceive is the impact on their health and quality of life?

    Source guidance details Comes from guidance Urinary tract infection in under 16s: diagnosis and management...

    Research recommendation
    Published
    4 August 2022

  11. Optilume for anterior urethral strictures (MIB241)

    NICE has developed a medtech innovation briefing (MIB) on Optilume for anterior urethral strictures .

    Medtech innovation briefing
    Published
    5 January 2021

  12. Bedwetting in children and young people (QS70)

    This quality standard covers assessing and managing bedwetting (nocturnal enuresis) in children and young people (aged 18 and under). It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    18 September 2014
    View quality statements

    Sections for QS70

  13. Embedding NICE guidance into GPSOC clinical systems

    optimisations which ensure that hypertension, CKD, AKI, asthma, urinary tract infections and diabetes are managed in accordance with...

    Shared learning
    Last updated
    1 September 2021

  14. Sotagliflozin with insulin for treating type 1 diabetes (TA622)

    Evidence-based recommendations on sotagliflozin with insulin for treating type 1 diabetes in adults with a body mass index (BMI) of at least 27 kg/m2 , when insulin alone does not provide adequate glycaemic control despite optimal insulin therapy.

    Technology appraisal guidance
    Published
    12 February 2020
    View recommendations

    Sections for TA622

  15. Urinary incontinence in women (QS77)

    This quality standard covers managing urinary incontinence in women (aged 18 and over). It covers assessment, care and treatment options. It describes high-quality care in priority areas for improvement.

    Quality standard
    Last updated
    9 December 2021
    View quality statements

    Sections for QS77